You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, Ill., Sept. 18, 2018 /PRNewswire/ -- Astellas today announced that Geoff Towle has been promoted to vice president, Oncology Marketing, Astellas US. In this role, Towle will be responsible for building Astellas Oncology brands with customers in large and specialty market segments through the development and implementation of innovative marketing methods. He will report to Mark Reisenauer, senior vice president, Oncology Business Unit.
"Astellas is committed to making a difference in the lives of cancer patients through an emphasis on innovation and R&D," said Reisenauer. "I am confident that Geoff's proven experience leading pipeline and in-line oncology brands in the US and globally across numerous tumors and other therapeutic areas will help Astellas continue reach its commercial goals, while always keeping patient needs at the center."
Previously, Towle served as senior director, Oncology Marketing at Astellas, where he led the development of brand strategies, messaging and tactics for XTANDI. Since joining the company in 2011, Towle led four best-in-class launches that have been highlighted within Astellas and across the industry based on speed of execution, quality, and performance. Prior to Astellas, Towle served in a variety of positions with increasing responsibility at Abbott Laboratories, Inc. (now AbbVie).
Towle holds a bachelor's in management from Bryant University and a master's in business administration from the University of Michigan.
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at http://www.astellas.us. You can also follow us on Twitter at @AstellasUS, Facebook at http://www.facebook.com/AstellasUS or LinkedIn at www.linkedin.com/company/astellas-pharma.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.